{"id":6736,"date":"2009-03-13T22:17:32","date_gmt":"2009-03-14T02:17:32","guid":{"rendered":"http:\/\/piel-l.org\/blog\/?p=6736"},"modified":"2009-03-14T07:06:51","modified_gmt":"2009-03-14T11:06:51","slug":"comunicados-sobre-efalizumabraptiva","status":"publish","type":"post","link":"https:\/\/piel-l.org\/blog\/6736","title":{"rendered":"Comunicados sobre Efalizumab\/Raptiva"},"content":{"rendered":"<ul>\n<li><a href=\"http:\/\/piel-l.org\/blog\/wp-content\/uploads\/\/2009\/03\/efalizumab.doc\" target=\"_blank\">Efalizumab: Otro alerta sobre leucoencefalopat\u00eda multifocal progresiva<\/a> <\/li>\n<li><a title=\"Ketoconazol: Se reducen las indicaciones &amp; Efalizumab: Otro alerta sobre leucoencefalopat\u00eda multifocal progresiva\" rel=\"bookmark\" href=\"http:\/\/piel-l.org\/blog\/6364\">Ketoconazol: Se reducen las indicaciones &amp; Efalizumab: Otro alerta sobre leucoencefalopat\u00eda multifocal progresiva<\/a><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Efalizumab: Otro alerta sobre leucoencefalopat\u00eda multifocal progresiva Ketoconazol: Se reducen las indicaciones &amp; Efalizumab: Otro alerta sobre leucoencefalopat\u00eda multifocal progresiva<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[14],"tags":[],"class_list":["post-6736","post","type-post","status-publish","format-standard","","category-farmacologia"],"_links":{"self":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/6736","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/comments?post=6736"}],"version-history":[{"count":0,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/posts\/6736\/revisions"}],"wp:attachment":[{"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/media?parent=6736"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/categories?post=6736"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/piel-l.org\/blog\/wp-json\/wp\/v2\/tags?post=6736"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}